Teva Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Teva Pharma (TEVA) Reports In-Line Q1 EPS, Reaffirms Outlook
May 11, 2017 7:03 AM EDTTeva Pharma (NYSE: TEVA) reported Q1 EPS of $1.06, in-line with the analyst estimate of $1.06. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.7 billion.
Dr. Peterburg continued, Looking forward to the rest of 2017, we are reaffirming our full-year... More
